[Federal Register: October 23, 2000 (Volume 65, Number 205)]
[Notices]
[Page 63257-63258]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23oc00-58]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Medical Devices Dispute Resolution Panel of the Medical Devices
Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Medical Devices Dispute Resolution Panel of the
Medical Devices Advisory Committee.
General Function of the Panel: To provide advice and
recommendations to the agency on scientific disputes between the Center
for Devices and Radiological Health and sponsors, applicants, and
manufacturers.
Date and Time: The meeting will be held on October 31, 2000, 1 p.m.
to 4 p.m.
Location: Corporate Bldg., conference room 020B, 9200 Corporate
Blvd., Rockville, MD.
Contact Person: Les S. Weinstein, Center for Devices and
Radiological Health (HFZ-5), Food and Drug Administration, 9200
Corporate Blvd., Rockville, MD 20850, e-mail: lsw@cdrh.fda.gov, or FDA
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in
the Washington, DC area), code 10232. Please call the Information Line
for up-to-date information on this meeting.
Agenda: The members of the newly established Medical Devices
Dispute Resolution Panel will be introduced to the public and will hear
presentations by FDA staff on the purpose of the panel and its role in
dispute resolution.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues regarding resolving scientific
disputes concerning medical devices and on the role of this panel.
Written submissions may be made to the contact person by October 25,
2000. Oral presentations from the public will be scheduled between
approximately 2 p.m. and 4 p.m. Time allotted for each presentation may
be limited. Those desiring to make formal oral presentations should
notify the contact person before October 25, 2000, and submit a brief
statement of the general nature of the evidence or arguments they wish
to present, the names and addresses of proposed participants, and an
indication of the approximate time requested to make their
presentation.
FDA regrets that it was unable to publish this notice 15 days prior
to the October 31, 2000, Medical Devices Dispute Resolution Panel of
the Medical Devices Advisory Committee meeting. Because the agency
believes there is some urgency to bring this issue to public discussion
and qualified members of the Medical Devices Dispute Resolution Panel
of the Medical Devices Advisory Committee were available at this time,
the Commissioner of Food and Drugs concluded that it was in the public
interest to hold this meeting even if there was not sufficient time for
the customary 15-day public notice.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
[[Page 63258]]
Dated: October 18, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-27228 Filed 10-19-00; 12:06 pm]
BILLING CODE 4160-01-F